Eriksen G V, Carlstedt I, Mörgelin M, Uldbjerg N, Malmström A
Y Forskningslaboratorium, Department of Obstetrics and Gynaecology, Faculty of Health Sciences, Aarhus University Hospital, Skejby Hospital, DK-8200 Aarhus N, Denmark.
Biochem J. 1999 Jun 15;340 ( Pt 3)(Pt 3):613-20.
Two proteoglycans differing in size and composition were isolated from human follicular fluid. The larger one of high density had a molecular mass of 3.0x10(6) Da, as determined by laser light-scattering, and was substituted with 15-20 chondroitin sulphate (CS) chains (Mr 60000-65000). Half of the CS disaccharides were 6-sulphated, whereas the remaining ones were non-sulphated. Digestion of the CS proteoglycan with chondroitinase ABC lyase, followed by SDS/PAGE, yielded a protein core of 600 to 700 kDa including substituted oligosaccharides, and a band of 70 kDa that was identified as the heavy-chain component of the inter-alpha-trypsin inhibitor (ITI). Western blotting of the CS proteoglycan showed that this had reactivity with antibodies raised against human versican. Electron microscopy (EM) of the CS proteoglycan also revealed a versican-like structure, with one globular domain at each end of a long extended segment substituted with CS side chains, as well as a structure interpreted as being the heavy chain of ITI attached to CS chains. Laser light-scattering revealed that the smaller proteoglycan had a molecular mass of 1. 1x10(6) Da, and EM demonstrated that it had a globular-protein core structure. The core protein, which showed immunological reactivity with perlecan antibodies, was substituted with approximately seven heparan sulphate (HS) and CS chains of similar size (50-55 kDa), the CS disaccharides being mainly 6-sulphated (68%), with a small proportion being 4-sulphated. The protein core was shown to be heterogeneous, with bands occurring at 215, 330 and 400 kDa after enzymic degradation of the glycosaminoglycan chains followed by SDS/PAGE analysis. The demonstration of intact molecules and fragments obtained after stepwise degradations, as shown by gel chromatography, supported a 'composite' structure of this proteoglycan.
从人卵泡液中分离出两种大小和组成不同的蛋白聚糖。通过激光散射测定,较大的高密度蛋白聚糖分子量为3.0×10⁶Da,它带有15 - 20条硫酸软骨素(CS)链(分子量60000 - 65000)。CS二糖的一半为6 - 硫酸化,其余为非硫酸化。用软骨素酶ABC裂解酶消化CS蛋白聚糖,随后进行SDS/PAGE分析,得到一个600至700kDa的包含取代寡糖的蛋白核心,以及一条70kDa的条带,该条带被鉴定为α-胰蛋白酶抑制剂(ITI)的重链成分。CS蛋白聚糖的蛋白质印迹显示,它与抗人多功能蛋白聚糖的抗体有反应性。CS蛋白聚糖的电子显微镜(EM)观察也显示出类似多功能蛋白聚糖的结构,在长延伸段的两端各有一个球状结构域,被CS侧链取代,还有一种结构被解释为附着在CS链上的ITI重链。激光散射显示较小的蛋白聚糖分子量为1.1×10⁶Da,EM表明它具有球状蛋白核心结构。核心蛋白与基底膜聚糖抗体有免疫反应性,它带有大约七条大小相似(50 - 55kDa)的硫酸乙酰肝素(HS)和CS链,CS二糖主要为6 - 硫酸化(68%),一小部分为4 - 硫酸化。在糖胺聚糖链经酶降解后进行SDS/PAGE分析,结果显示蛋白核心是异质的,出现了215、330和400kDa的条带。凝胶色谱显示的逐步降解后完整分子和片段的情况,支持了这种蛋白聚糖的“复合”结构。